Please login to the form below

6 critical success factors for flawless execution of a rapid first commercial launch

Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline.

The success of any drug launch begins long before a regulatory agency gives the product the green light. From clinical development to commercialization, cross‑functional team collaboration is critical when bringing a new drug to market—even more so when the product is fast‑tracked or receives priority review. In the case of a company’s first commercial launch, the metaphor “building the plane while flying it” is often cited because so much is in progress.

As companies move from research and development (R&D) to commercialization, there are important decisions to be made and infrastructure required to support manufacturing, distribution, access, marketing, and sales—all of which are typically underway as pivotal trials are nearing completion. With a rapid approval of a first commercial product, launch planning fundamentals are even more important when every minute of every day counts.

Fishawack Health has had the privilege of working on dozens of new drug launches in recent years as the Brand Agency of Record—working with many biotech and biopharma companies on their first commercial launch. We’ve identified 6 critical success factors for fast-paced first commercial launches.


In a more condensed launch timetable, multiple workstreams run in parallel and must move quickly. Cross-functional teams may not have the time or attention to detail to see how one workstream impacts another. Creation of an internal launch readiness team to oversee and align multiple, overlapping workstreams is fundamental, but some companies may not be fully staffed to do this in the run-up to a rapid launch.

Whether employing internal teams or outside partners, these team members should be part of key meetings and discussions to help the organization look at the individual workstreams in context of the big picture and connect the dots when needed. Disconnects can be surfaced by the launch readiness team with the help of their partners. Issues can be readily escalated to decision-makers and course‑corrections made quickly. The launch readiness team keeps teams on task, on time, and accountable.


19th January 2022



Company Details

Fishawack Health

+44 20 3328 1840

Contact Website

No. 3 Booths Park
Booths Hall
Chelford Road
WA16 8GS
United Kingdom

Latest content on this profile

Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities
As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.
Fishawack Health
Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies
Fishawack Health welcomes Harriet Shurville to the team as Chief People Officer to spearhead integration efforts, champion diversity and inclusion, and cultivate an environment where interdisciplinary teams thrive.
Fishawack Health
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the implications for products and portfolios across the development life cycle.
Fishawack Health
Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer
Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.
Fishawack Health
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts provide insights on the trends, challenges and opportunities for biopharmaceutical companies, including why an interdisciplinary approach is needed to improve outcomes in oncology.
Fishawack Health
The challenges of reimbursement and innovative pricing for cell and gene therapies
Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of innovative pricing models, including ensuring the model chosen meets the payer’s needs.
Fishawack Health